{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-331563","form_type":"8-K","ticker":"SNSE","cik":"0001829802","company_name":"Sensei Biotherapeutics, Inc.","filed_at":"2026-08-04T11:40:27+00:00","discovered_at":"2026-08-04T11:45:00.396962+00:00","generated_at":"2026-08-04T11:45:27.919818+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Faeth Therapeutics Q2 2026 net loss $16.0M; cash $186.4M; Phase 2 PIK-201 data expected year-end","bullets":["Net loss of $16.0M ($2.84 per share) for Q2 2026, compared to $4.9M ($3.91 per share) in Q2 2025.","Cash, cash equivalents and marketable securities of $186.4M as of June 30, 2026, up from $21.2M at Dec 31, 2025, reflecting $200M PIPE financing.","Topline results from Phase 2 PIK-201 trial in endometrial cancer on track for year-end 2026.","First patient dosed in Phase 1b/2 PIK-101 trial in HR+ breast cancer in April 2026.","Company changed name to Faeth Therapeutics and began trading under ticker FTH on June 16, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-331563","json":"https://secwatch.observer/filing/0001193125-26-331563.json","markdown":"https://secwatch.observer/filing/0001193125-26-331563.md","text":"https://secwatch.observer/filing/0001193125-26-331563.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1829802/000119312526331563/0001193125-26-331563-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1829802/000119312526331563/d168633d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-04T11:45:27.919818+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}